Products
CCNB2 antibody
- Product Name
- CCNB2 antibody
- Catalogue No.
- FNab02123
- Size
- 100μg
- Form
- liquid
- Purification
- Immunogen affinity purified
- Purity
- ≥95% as determined by SDS-PAGE
- Clonality
- polyclonal
- Isotype
- IgG
- Storage
- PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months (Avoid repeated freeze / thaw cycles.)
Immunogen
- Immunogen
- cyclin B2
- Alternative Names
- G2/mitotic-specific cyclin-B2|CCNB2 antibody
- UniProt ID
- O95067
- Observed MW
- 50 kDa
Application
- Tested Applications
- ELISA, WB, IHC, IP
- Recommended dilution
- WB: 1:500 - 1:2000; IHC: 1:100 - 1:200; IP: 1:500-1:1000
Validated Images
A431 cells were subjected to SDS PAGE followed by western blot with FNab02123(CCNB2 antibody) at dilution of 1:1000
IP Result of anti-CCNB2 (IP: FNab02123, 4ug; Detection: FNab02123 1:1000) with A431 cells lysate 2000ug.
Immunohistochemistry of paraffin-embedded human cervical cancer tissue slide using FNab02123(CCNB2 Antibody) at dilution of 1:200
- Background
- Cyclin B2 is a member of the cyclin family, specifically the B-type cyclins. The B-type cyclins, B1 and B2, associate with p34cdc2 and are essential components of the cell cycle regulatory machinery. B1 and B2 differ in their subcellular localization. Cyclin B1 co-localizes with microtubules, whereas cyclin B2 is primarily associated with the Golgi region. Cyclin B2 also binds to transforming growth factor beta RII and thus cyclin B2/cdc2 may play a key role in transforming growth factor beta-mediated cell cycle control.
